Feng Chi Biotech Corp. (TPEX:6744)
Taiwan · Delayed Price · Currency is TWD 15.00
0.00 (0.00%)
Oct 8, 2026, 10:35 AM CST
Feng Chi Biotech Market Cap
Feng Chi Biotech has a market cap or net worth of 231 million as of October 9, 2026. It is the 43,382nd most valuable company in the world and the 2,339th biggest in Taiwan. Its market cap has decreased by 26.11% in one year.
Market Cap
231.00M
Enterprise Value
63.69M
Revenue
156.99M
Global Rank
Country Rank
#2,339 Taiwan
PE Ratio
23.32
ChartMarket Cap Chart
Since September 25, 2019, Feng Chi Biotech's market cap has decreased from 742.28M to 231.00M, a decrease of -68.88%. That is a compound annual growth rate of -15.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 231.00M | -15.73% |
| Dec 31, 2025 | 274.12M | -10.10% |
| Dec 30, 2024 | 304.92M | -10.81% |
| Dec 29, 2023 | 341.88M | 11.00% |
| Dec 29, 2022 | 308.00M | -19.19% |
| Dec 28, 2021 | 381.15M | -16.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NatureWise Biotech & Medicals | 814.07M |
| Lukas Biomedical | 774.68M |
| BioLASCO Taiwan | 729.94M |
| Neith | 703.95M |
| Taiwan Advance Bio-Pharmaceutical | 679.50M |
| SynCore Biotechnology Co.,Ltd | 625.94M |
| TaiwanJ Pharmaceuticals | 564.06M |
| Vectorite Biomedical | 529.63M |